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Abstract 
 
v-Src protein tyrosine kinase is the product of the transforming gene 
transduced by avian Rous sarcoma virus. In contrast to proto-oncogene c-src, 
v-src lacks the negative-regulatory C-terminal domain and consequently shows 
a higher level of activity and transforming ability. In addition, v-Src contains 
point mutations throughout its coding region that probably contribute to the 
high level of intrinsic kinase activity. Long terminal repeats (LTR) comprise 
strong promoter-enhancer sequences and ensure efficient expression of the  
v-src gene. v-Src protein has a strong transforming potential in vitro and 
induces tumor development and growth in vivo. Moreover, it is implicated in 
metastatic formation. In several cancer types the elevated c-Src kinase activity 
caused pleiotropic cellular responses inducing transformation and metastasis.  
The aim of this diploma work was to reveal the role of v-Src in mediating  
tumor and metastatic progression in chicken cell lines PR9692 and  
PR9692-E9. Despite the low propensity of the chicken cells to immortalization, 
comparatively high immoratlization efficiency was observed in cells from  
ex vivo tumours growing progressively in chickens of the inbred line CC.R1. 
Among them are these two cell lines that originate from tumors induced in 
chickens of the inbred line CC.R1 by employing the moleculary cloned LTR,  
v-src, LTR proviral DNA. PR9692-E9 is a subclone of PR9692 derived in vitro 
by limiting dilution.  Both cell lines overexpress transforming protein v-Src, but 
they differ in metastatic properties. Line PR9692 induces metastatic 
progression after inoculation in chicks whereas line PR9692-E9 does not. To 
study the role of v-Src we used short interfering RNA to silence v-src 
expression in the process that is known as RNA interference. We have 
prepared cell lines PR9692 and PR9692-E9 that stably express shRNA 
mediating knock-down of v-src expression. Knock-down is provided by 
plasmid-based gene silencing. We employed three different shRNA constructs 
that targeted v-src. The knockdown effect slightly varried among different 
constructs. The most significant reduction in v-src expression was acquired by 
shRNA against the v-src coding region compared with shRNA against the 
leader sequence or U3 region of v-src. The expression of v-src mRNA and 
protein were analyzed by RT-PCR and Western blot.  
PR9692 and PR9692-E9 cells with reduced expression of v-src were 
inoculated into chickens to reveal whether the level of v-Src in these cells  
correlates with tumor induction and metastatic potential. We demonstrated that 
v-src is one of the genes playing an essential role in maintaining malignant 
phenotypes. In most cases inhibition of v-src in cell line PR9692 decreased the 
incidence of metastases, moreover the growth of primary tumors declined in all 
cases.  
We conclude that the level of v-Src influences the primary tumor growth 
and the metastatic potential. 
 
